Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.

Moraes FY, Winter J, Atenafu EG, Dasgupta A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB.

Neuro Oncol. 2019 Feb 14;21(2):242-251. doi: 10.1093/neuonc/noy159.

PMID:
30265328
2.

Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis.

Patel RA, Lock D, Helenowski IB, Chandler JP, Tate MC, Bloch O, Sachdev S, Kruser TJ.

J Neurooncol. 2018 Nov;140(2):395-401. doi: 10.1007/s11060-018-2965-7. Epub 2018 Aug 6.

PMID:
30084023
3.

Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.

Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, Fogh SE, Nakamura JL, McDermott MW.

J Neurosurg. 2015 Aug;123(2):373-86. doi: 10.3171/2014.10.JNS141610. Epub 2015 May 15.

PMID:
25978710
4.

First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

Cancer Med. 2017 Sep;6(9):2076-2086. doi: 10.1002/cam4.1149. Epub 2017 Aug 4.

5.

Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):996-1001. doi: 10.1016/j.ijrobp.2009.06.006. Epub 2009 Sep 23.

PMID:
19783374
6.

Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.

Prabhu RS, Miller KR, Asher AL, Heinzerling JH, Moeller BJ, Lankford SP, McCammon RJ, Fasola CE, Patel KR, Press RH, Sumrall AL, Ward MC, Burri SH.

J Neurosurg. 2018 Dec 1:1-8. doi: 10.3171/2018.7.JNS181293. [Epub ahead of print]

PMID:
30554174
7.

Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.

Prabhu RS, Press RH, Patel KR, Boselli DM, Symanowski JT, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola CE, Asher AL, Sumrall AL, Buchwald ZS, Curran WJ Jr, Shu HG, Crocker I, Burri SH.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):459-467. doi: 10.1016/j.ijrobp.2017.04.006. Epub 2017 Apr 11.

PMID:
28871997
8.

Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Ohtakara K, Hayashi S, Nakayama N, Ohe N, Yano H, Iwama T, Hoshi H.

J Neurooncol. 2012 May;108(1):201-9. doi: 10.1007/s11060-012-0834-3. Epub 2012 Mar 6.

PMID:
22392126
9.

Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.

Minniti G, Paolini S, D'Andrea G, Lanzetta G, Cicone F, Confaloni V, Bozzao A, Esposito V, Osti M.

J Neurooncol. 2017 May;132(3):455-462. doi: 10.1007/s11060-017-2394-z. Epub 2017 Mar 4.

PMID:
28260130
10.

A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.

Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, Chan TA, Lymberis SC, Narayana A, Tabar V, Gutin PH, Ballangrud Å, Lis E, Beal K.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):130-6. doi: 10.1016/j.ijrobp.2013.09.051.

11.

The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.

Miller JA, Balagamwala EH, Berriochoa CA, Angelov L, Suh JH, Benzel EC, Mohammadi AM, Emch T, Magnelli A, Godley A, Qi P, Chao ST.

J Neurosurg Spine. 2017 Oct;27(4):436-443. doi: 10.3171/2017.3.SPINE161015. Epub 2017 Jul 21.

PMID:
28731393
12.

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM.

Radiat Oncol. 2011 May 15;6:48. doi: 10.1186/1748-717X-6-48.

13.

Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.

Singh C, Qian JM, Yu JB, Chiang VL.

J Neurosurg. 2019 Feb 15:1-6. doi: 10.3171/2018.10.JNS181371. [Epub ahead of print]

PMID:
30771783
14.

Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.

Kirkpatrick JP, Wang Z, Sampson JH, McSherry F, Herndon JE 2nd, Allen KJ, Duffy E, Hoang JK, Chang Z, Yoo DS, Kelsey CR, Yin FF.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):100-8. doi: 10.1016/j.ijrobp.2014.09.004. Epub 2014 Oct 21.

PMID:
25442342
15.

Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.

Fang P, Jiang W, Allen P, Glitza I, Guha N, Hwu P, Ghia A, Phan J, Mahajan A, Tawbi H, Li J.

J Neurooncol. 2017 Jul;133(3):595-602. doi: 10.1007/s11060-017-2470-4. Epub 2017 May 12.

PMID:
28500560
16.

Stereotactic radiosurgery for the treatment of brain metastasis from gastrointestinal primary cancers.

Paudel N, Helenowski I, Kane L, Sachdev S, Bloch O, Tate M, Chandler JP, Kruser TJ.

J Radiosurg SBRT. 2019;6(1):27-34.

17.

Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.

Lischalk JW, Oermann E, Collins SP, Nair MN, Nayar VV, Bhasin R, Voyadzis JM, Rudra S, Unger K, Collins BT.

Radiat Oncol. 2015 Oct 26;10:216. doi: 10.1186/s13014-015-0525-2.

18.

Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.

Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C, Chen Z, Kandula S, Zhong J, Press RH, Olson JJ, Oyesiku NM, Wait SD, Curran WJ, Shu HK, Prabhu RS.

Neurosurgery. 2016 Aug;79(2):279-85. doi: 10.1227/NEU.0000000000001096.

PMID:
26528673
19.

Stereotactic radiosurgery for small brain metastases and implications regarding management with systemic therapy alone.

Trifiletti DM, Hill C, Cohen-Inbar O, Xu Z, Sheehan JP.

J Neurooncol. 2017 Sep;134(2):289-296. doi: 10.1007/s11060-017-2519-4. Epub 2017 Jun 2.

PMID:
28577030
20.

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106.

PMID:
15234044

Supplemental Content

Support Center